Page last updated: 2024-10-16

quinacrine and Precursor Cell Lymphoblastic Leukemia-Lymphoma

quinacrine has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wu, L1
Chatla, S1
Lin, Q1
Chowdhury, FA1
Geldenhuys, W1
Du, W1

Other Studies

1 other study available for quinacrine and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia.
    Nature communications, 2021, 11-26, Volume: 12, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Cell Line, Tumor; Cytarabine; D

2021